Vicapsys Life Valuation
| VICP Stock | USD 7.00 0.00 0.00% |
At this time, the company appears to be fairly valued. Vicapsys Life Sciences has a current Real Value of $7.0 per share. The regular price of the company is $7.0. Our model measures the value of Vicapsys Life Sciences from inspecting the company fundamentals such as Shares Outstanding of 31.19 M, return on equity of -10.59, and Price To Book of 0.02 X as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Vicapsys Life's price fluctuation is very steady at this time. Calculation of the real value of Vicapsys Life Sciences is based on 3 months time horizon. Increasing Vicapsys Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Vicapsys Life's intrinsic value may or may not be the same as its current market price of 7.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.0 | Real 7.0 | Hype 7.0 |
The intrinsic value of Vicapsys Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Vicapsys Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Vicapsys Life Sciences helps investors to forecast how Vicapsys pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vicapsys Life more accurately as focusing exclusively on Vicapsys Life's fundamentals will not take into account other important factors: Vicapsys Life Total Value Analysis
Vicapsys Life Sciences is at this time forecasted to have valuation of 31.17 M with market capitalization of 31.19 M, debt of 0, and cash on hands of 17.29 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Vicapsys Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
31.17 M | 31.19 M | 0 | 17.29 K |
Vicapsys Life Asset Utilization
One of the ways to look at asset utilization of Vicapsys is to check how much profit was generated for every dollar of assets it reports. Vicapsys Life Sciences has a negative utilization of assets of -0.8 %, losing $0.00796 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Vicapsys Life Sciences shows how discouraging it operates for each dollar spent on its assets.Vicapsys Life Ownership Allocation
Vicapsys Life Sciences shows a total of 31.19 Million outstanding shares. Vicapsys Life Sciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Vicapsys Life Profitability Analysis
Net Loss for the year was (765.84 K) with profit before overhead, payroll, taxes, and interest of 0.About Vicapsys Life Valuation
The pink sheet valuation mechanism determines Vicapsys Life's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Vicapsys Life Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vicapsys Life. We calculate exposure to Vicapsys Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vicapsys Life's related companies.Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN proprietary product. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia. Vicapsys Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
8 Steps to conduct Vicapsys Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Vicapsys Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Vicapsys Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Vicapsys Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Vicapsys Life's revenue streams: Identify Vicapsys Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Vicapsys Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Vicapsys Life's growth potential: Evaluate Vicapsys Life's management, business model, and growth potential.
- Determine Vicapsys Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Vicapsys Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Vicapsys Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Vicapsys Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 17.5 M | |
| Retained Earnings | -13.9 M | |
| Shares Float | 13 M |
Additional Tools for Vicapsys Pink Sheet Analysis
When running Vicapsys Life's price analysis, check to measure Vicapsys Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicapsys Life is operating at the current time. Most of Vicapsys Life's value examination focuses on studying past and present price action to predict the probability of Vicapsys Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicapsys Life's price. Additionally, you may evaluate how the addition of Vicapsys Life to your portfolios can decrease your overall portfolio volatility.